{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:15:32Z","timestamp":1793153732477,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001449.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T00:00:00Z","timestamp":1375228800000}}],"reference-count":176,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001449.pub3","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T07:50:04Z","timestamp":1375257004000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Drugs for treatment of very high blood pressure during pregnancy"],"prefix":"10.1002","volume":"2013","author":[{"given":"Lelia","family":"Duley","sequence":"first","affiliation":[{"name":"Nottingham Health Science Partners; Nottingham Clinical Trials Unit; C Floor, South Block Queen's Medical Centre Nottingham UK NG7 2UH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Meher","sequence":"additional","affiliation":[{"name":"The University of Liverpool; Department of Women's and Children's Health; First Floor, Liverpool Women's NHS Foundation Trust Crown Street Liverpool UK L8 7SS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Jones","sequence":"additional","affiliation":[{"name":"The University of Liverpool; Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health; First Floor, Liverpool Women's NHS Foundation Trust Crown Street Liverpool UK L8 7SS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,31]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10641959009012940","article-title":"Effectiveness of antihypertensive drugs in the treatment of hypertension in pregnancy","volume":"9","author":"Voto","year":"1990","journal-title":"Clinical and Experimental Hypertension - Part B Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1479-828X.1986.tb01523.x","article-title":"Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy","volume":"26","author":"Michael","year":"1986","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001449.pub3-BIB0003|cit3","first-page":"22","article-title":"Parenteral intravenous optimal therapy trial - A RCT of hydralazine versus mini-bolus diazoxide for hypertensive crises in the obstetric setting [abstract]","volume":"25","author":"Hennessy","year":"2006","journal-title":"Hypertension in Pregnancy"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1479-828X.2007.00738.x","article-title":"A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the pivot trial","volume":"47","author":"Hennessy","year":"2007","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0005|cit5","unstructured":"Hennessy AM Diazoxide versus hydralazine for acute treatment of very high blood pressure in pregnancy Personal communication"},{"issue":"1","key":"10.1002\/14651858.CD001449.pub3-BIB0006|cit6","first-page":"25","article-title":"Randomized, controlled trial of hydralazine versus nifedpine in preeclamptic women with acute hypertension","volume":"B11","author":"Martins-Costa","year":"1992","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0007|cit7","doi-asserted-by":"crossref","unstructured":"Mesquita MR Attalah AN Camano L Bertini AM The use of hydralazine and nifedipine as treatment of hypertension emergency during pregnancy Proceedings of 2nd World Congress of Perinatal Medicine; 1993 September 19-24; Rome, Italy 1993 41","DOI":"10.1016\/0165-0378(93)90019-E"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0008|cit8","first-page":"90","article-title":"Use of hydralazine and nifedipine in hypertensive emergency in pregnancy","volume":"37","author":"Souza","year":"1994","journal-title":"Progresos de Obstetricia y Ginecologia"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0009|cit9","unstructured":"de Souza Mesquita MR Atallah AN Bertini AM The use of hydralazine and nifedipine as treatment for hypertension emergency during pregnancy Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland 1994 163"},{"issue":"1","key":"10.1002\/14651858.CD001449.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ultrasmedbio.2010.10.006","article-title":"Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial","volume":"37","author":"Baggio","year":"2011","journal-title":"Ultrasound in Medicine & Biology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1185\/03007998209110129","article-title":"The treatment of hypertension in pregnancy","volume":"8","author":"Moore","year":"1982","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0012|cit12","first-page":"S48","article-title":"Urapidyl for hypertension control in severe pre-eclampsia: a comparative study with nicardipine","volume":"14 Suppl 1","author":"Vizitiu","year":"2010","journal-title":"Critical Care"},{"issue":"9","key":"10.1002\/14651858.CD001449.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-2001-18226","article-title":"Effect of urapidil in antihypertensive therapy of preeclampsia on newborns","volume":"123","author":"Schulz","year":"2001","journal-title":"Zentralblatt fur Gynakologie"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0014|cit14","first-page":"121","article-title":"Treatment of patients with pre-eclampsia with urapidil","volume":"46","author":"Wacker","year":"1994","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0015|cit15","unstructured":"Wacker J Christ M Muller J Grischke EM Bastert G Treatment of patients with pre-eclampsia with urapidil Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland 1994 186"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0016|cit16","unstructured":"Wacker J Piel P Bastert G The treatment of pre-eclampsia with urapidil Proceedings of 10th World Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 185"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0017|cit17","unstructured":"Wacker J Schulz M Werner P Bastert G Fetal outcome after treatment of hypertension in patients with preeclampsia with urapidil [abstract] 12th World Congress of the International Society for the Study of Hypertension in Pregnancy; 2000 July 9-15; Paris, France 2000 1"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/oxfordjournals.ndt.a027825","article-title":"Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil","volume":"13","author":"Wacker","year":"1998","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD001449.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejogrb.2005.09.013","article-title":"Antihypertensive therapy in patients with pre-eclampsia: a prospective randomised multicentre study comparing dihydralazine with urapidil","volume":"127","author":"Wacker","year":"2006","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0020|cit20","unstructured":"Aswathkumar R Gilvaz S Management of severe hypertension in pregnancy: prospective comparison of labetalol vs nifedipine [abstract] 49th All India Congress of Obstetrics and Gynaecology; 2006 Jan 6-9; Cochin, Kerala State, India 2006 38"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0021|cit21","unstructured":"Desai BB Swamy MK Patil KP A randomized controlled trial of oral nifedipine vs intravenous labetalol in acute control of blood pressure in hypertensive emergencies of pregnancy 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India 2011 179"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-0412.2002.810105.x","article-title":"Nifedipine or hydralazine as a first-line agent to control hypertension in severe pre-eclampsia","volume":"81","author":"Aali","year":"2002","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"11","key":"10.1002\/14651858.CD001449.pub3-BIB0023|cit23","first-page":"701","article-title":"Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy","volume":"49","author":"Rezaei","year":"2011","journal-title":"Acta Medica Iranica"},{"issue":"1","key":"10.1002\/14651858.CD001449.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-0528.2011.03151.x","article-title":"Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial","volume":"119","author":"Raheem","year":"2012","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0025|cit25","first-page":"359","article-title":"Severe preeclamsia. Nifedipine versus chlorpromazine in the management of the acute hypertensive state","volume":"27","author":"Rodriguez","year":"1989","journal-title":"Revista Medica Instituto Mexicano del Seguro Social"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0026|cit26","first-page":"76","article-title":"Management of severe pre-eclampsia\/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive drugs","volume":"61","author":"Walss Rodriguez","year":"1993","journal-title":"Ginecologia y Obstetricia de Mexico"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0027|cit27","first-page":"316","article-title":"Efficacy of isosorbide in aerosol form in the management of hypertensive crisis in severe preeclampsia","volume":"66","author":"Vargas","year":"1998","journal-title":"Ginecologia y Obstetricia de Mexico"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD001449.pub3-BIB0029|cit28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0002-9378(95)91140-5","article-title":"Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe early onset pre-eclampsia","volume":"172","author":"Bolte","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0030|cit29","unstructured":"Bolte AC Dekker GA van Eyck J Bruinse HW Kanhai HH de Vries A Ketanserin versus dihydralazine in the treatment of early onset pre-eclampsia Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 148"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0028|cit30","unstructured":"Bolte AC Dekker GA van Eyck J Bruinse HW Kanhai HH de Vries A Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe early onset preeclampsia Proceedings of the International Society for the Study of Hypertension in Pregnancy, European Branch; 1995 July 20-22; Leuven Belgium 1995 18"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0031|cit31","unstructured":"Bolte AC Dekker GA van Eyck J Strack van Schijndel RJM de Vries A van Geijn HP Comparison of the effectivity and safety of ketanserin vs dihydralazine in the treatment of severe pre-eclampsia Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia 1994 42"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0002-9378(99)70216-4","article-title":"Ketanserin versus dihydralazine in the management of severe early onset preeclampsia: maternal outcome","volume":"180","author":"Bolte","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1471-0528.1998.tb10202.x","article-title":"The haemodynamic effects of ketanserin versus dihydralazine in severe early onset hypertension in pregnancy","volume":"105","author":"Bolte","year":"1998","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD001449.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/S0002-9378(01)80357-4","article-title":"Use of ketanserin in hypertensive disorders of pregnancy [abstract]","volume":"185","author":"Bolte","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001449.pub3-BIB0035|cit35","first-page":"9","article-title":"Ketanserin, a serotonin2 receptor blocker, for hypertension in pregnancy","volume":"21","author":"Bolte","year":"2002","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0036|cit36","first-page":"179","article-title":"Ketanserin for hypertension in pregnancy","volume":"43","author":"Bolte","year":"2003","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD001449.pub3-BIB0037|cit37","first-page":"S7","article-title":"Interim report of the nimodipine vs. magnesium sulfate for seizure prophylaxis in severe preeclampsia study: an international, randomized controlled trial","volume":"178","author":"Belfort","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD001449.pub3-BIB0038|cit38","first-page":"S114","article-title":"Change in estimated cerebral perfusion pressure following nimodipine or magnesium sulfate in patients with severe preeclampsia","volume":"178","author":"Belfort","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJMoa021180","article-title":"A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia","volume":"348","author":"Belfort","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0002-9378(99)70569-7","article-title":"Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia","volume":"181","author":"Belfort","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0041|cit41","first-page":"288","article-title":"A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia","volume":"5","author":"Hollenberg","year":"2003","journal-title":"Current Hypertension Reports"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.1991.tb10339.x","article-title":"Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol","volume":"98","author":"Harper","year":"1991","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2006.02.015","article-title":"Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial","volume":"128","author":"Vigil-De Gracia","year":"2006","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0044|cit44","first-page":"354","article-title":"Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy","volume":"71","author":"Ashe","year":"1987","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0045|cit45","unstructured":"Moodley J The use of nifedipine in acute hypertensive emergencies of pregnancy Proceedings of 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Canada 1988 141"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0046|cit46","first-page":"248","article-title":"Nifedipine in acute hypertensive emergencies in pregnancy","volume":"76","author":"Seabe","year":"1989","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1471-0528.1992.tb13872.x","article-title":"A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy","volume":"99","author":"Moodley","year":"1992","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0048|cit48","first-page":"525","article-title":"Ketanserin and hydralazine in hypertension in pregnancy - a randomised double-blind trial","volume":"85","author":"Rossouw","year":"1995","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10641959709031638","article-title":"A randomized controlled pilot study comparing urapidil to dihydralazine in the management of severe hypertension in pregnancy","volume":"16","author":"Howarth","year":"1997","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0050|cit50","unstructured":"Pattinson RC Seris A Venter CP Howarth G Urapidil versus dihydralazine for control of severe hypertension in pregnancy: a pilot study Proceedings of the 12th Conference on Priorities in Perinatal Care; 1993; South Africa 1993 140 3"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10641959709069085","article-title":"A comparative study of intravenous isradipine and dihydralazine in the treatment of severe hypertension of pregnancy in black patients","volume":"16","author":"Maharaj","year":"1997","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0052|cit52","unstructured":"Maharaj B Moodley J Khedun SM Rapiti N van der Byl K Intravenous isradipine in the management of severe hypertension in pregnancy Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 131"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0053|cit53","unstructured":"Maharaj B Moodley J Khedun SM Rapiti N van der Byl K Intravenous isradipine in the management of severe hypertension in pregnancy Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia 1994 158"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0054|cit54","unstructured":"Steyn DW Odendaal HJ Dihydralazine or ketanserin for severe hypertension in pregnancy? Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 March 15-18; Sydney, Australia 1994 152"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0301-2115(97)00123-1","article-title":"Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results","volume":"75","author":"Steyn","year":"1997","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0056|cit56","unstructured":"Hall D Odendaal H Steyn D Smith M Carstens E Prazosin or nifedipine as a second agent to control early severe hypertension in pregnancy - a randomized controlled trial 29th Congress of the South African Society of Obstetricians and Gynaecologists; 1998 March 8-12; South Africa 1998"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1471-0528.2000.tb13337.x","article-title":"Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial","volume":"107","author":"Hall","year":"2000","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001449.pub3-BIB0058|cit58","first-page":"12","article-title":"Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial","volume":"19","author":"Hall","year":"2000","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0059|cit59","unstructured":"Hall DR Odendaal HJ Steyn DW Smith M Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial Women's Health - into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3-6; Cape Town South Africa RCOG 1999 49"},{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.preghy.2012.04.015","article-title":"Which first-line drug to control severe hypertension in pregnancy? A pilot study","volume":"2","author":"Saudan","year":"2012","journal-title":"Pregnancy Hypertension"},{"issue":"9","key":"10.1002\/14651858.CD001449.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00134-002-1406-3","article-title":"Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol","volume":"28","author":"Elatrous","year":"2002","journal-title":"Intensive Care Medicine"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0062|cit62","unstructured":"Belfort M Taskin O Buhur A Saade G Yalcinoglu A Intravenous nimodipine in the management of severe preeclampsia: a double blind randomised controlled clinical trial Proceedings of 10th International Congress, International Society for the Study of Hypertension in Pregnancy; 1996 August 4-8; Seattle, USA 1996 124"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0063|cit63","unstructured":"Mabie WC Gonzalez AR Amon E Sibai BM A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986; San Antonio, USA 1986 221"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0064|cit64","first-page":"328","article-title":"A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy","volume":"70","author":"Mabie","year":"1987","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0065|cit65","unstructured":"Mabie WC Gonzalez-Ruiz A Amon E Sibai BM A comparative trial of labetolol and hydralazine for acute management of severe hypertension complicating pregnancy Proceedings of 5th International Congress, International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK 1987 91"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/jp.2008.224","article-title":"The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial","volume":"29","author":"Adair","year":"2009","journal-title":"Journal of Perinatology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S2210-7789(10)60093-1","article-title":"Digoxin Immune Fab treatment for severe preeclampsia; relationship between response and baseline endogenous digitalis-like factor","volume":"1 Suppl 1","author":"Adair","year":"2010","journal-title":"Pregnancy Hypertension"},{"issue":"8","key":"10.1002\/14651858.CD001449.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1055\/s-0030-1249762","article-title":"Digoxin immune fab treatment for severe preeclampsia","volume":"27","author":"Adair","year":"2010","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0069|cit69","unstructured":"Anonymous Sildenafil citrate for the treatment of established pre-eclampsia (ongoing trial) ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0070|cit70","unstructured":"Voto L Lapidus A Neira J Margulies M Atenolol versus alpha methyl dopa in the treatment of hypertension in pregnancy Proceedings of the 5th International Congress, International Society for the Study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, UK, 1986 1986 138"},{"issue":"1","key":"10.1002\/14651858.CD001449.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.29309\/TPMJ\/2007.14.01.3619","article-title":"Pregnancy induced hypertension; anti-hypertensive therapy in a study using single drug versus multiple drugs","volume":"14","author":"Aslam","year":"2007","journal-title":"Professional Medical Journal"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1067\/mob.2002.126294","article-title":"Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy","volume":"187","author":"Brown","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0073|cit73","doi-asserted-by":"crossref","unstructured":"Buddle ML Brown MA Farrell T Rapid treatment of severe hypertension in pregnancy 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology; 2001 September 5-7; Darwin, Australia 2001 118","DOI":"10.1046\/j.1440-1797.2002.00007-1-118.x"},{"issue":"5","key":"10.1002\/14651858.CD001449.pub3-BIB0074|cit74","first-page":"1","article-title":"Management of hypertensive emergencies of pregnancy by hydralazine bolus injection vs continuous drip--a comparative study","volume":"7","author":"Begum","year":"2002","journal-title":"Medscape Womens Health eJournal"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0075|cit75","unstructured":"Belfort MA Labetalol versus MgSO4 for the prevention of eclampsia trial (ongoing trial) ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0076|cit76","unstructured":"Kahhale S Carrara W Barros ACSD Zugaib M Neme B A comparative study between treated (beta-blocker pindolol) and untreated chronic hypertension 4th World Congress of the International Society for the study of Hypertension in Pregnancy; 1984 June 18-21; Amsterdam, The Netherlands 1984 56"},{"issue":"2","key":"10.1002\/14651858.CD001449.pub3-BIB0077|cit77","first-page":"85","article-title":"Comparative study of chronic hypertensive pregnant women treated and non-treated with pindolol","volume":"8","author":"Kahhale","year":"1985","journal-title":"Ginecologia e Obstetricia Brasileiras"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0078|cit78","first-page":"75","article-title":"Nifedipine versus hydralazine: randomized, placebo-controlled and double blind trial in severe hypertension complicating pregnancy","volume":"8","author":"Bruno","year":"1988","journal-title":"Revista do Hospital de Clinicas de Porto Alegre"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0079|cit79","unstructured":"Atallah A Delascio D Santos J Mesquita G Kenj G Double blinded randomized controlled study using hydralazine or nifedipine for hypertensives crisis in pregnancy World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil 1988 181"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0080|cit80","first-page":"10","article-title":"A randomized controlled study of hydralazine and nifedipine in hypertensive crisis during pregnancy","volume":"12","author":"Atallah","year":"1990","journal-title":"Revista Brasileira de Ginecologia y Obstetricia"},{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0081|cit81","first-page":"151","article-title":"The effect of nifedipine on postpartum blood loss in patients with pregnancy induced hypertension [Chinese]","volume":"35","author":"Yang","year":"2000","journal-title":"Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics & Gynecology]"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0082|cit82","first-page":"287","article-title":"Intravenous labetalol versus oral nifedipine in the treatment of severe hypertension in pregnancy","volume":"44","author":"Devi","year":"2012","journal-title":"Kuwait Medical Journal"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0083|cit83","unstructured":"Egerman R Evaluation of the safety of relaxin in severe preeclampsia ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0084|cit84","unstructured":"Salem H Ghanemah S Seleem S Sayed E Abdel-Latif A Chard T Bromocriptine therapy in pre-eclamptic toxaemia of pregnancy (PET) World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil, 1988 1988 184"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/01443618909151031","article-title":"Management of severe pre-eclampsia with prostaglandin A1: a useful therapeutic approach","volume":"9","author":"Toppozada","year":"1989","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/00016349209007942","article-title":"Improving placental blood flow in pre-eclampsia with prostaglandin A1","volume":"71","author":"Toppozada","year":"1992","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jcrc.2009.02.001","article-title":"Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit","volume":"24","author":"Esmaoglu","year":"2009","journal-title":"Journal of Critical Care"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0088|cit88","unstructured":"Fievet P El Esper N Gueroult J Gueroult J Fournier A Comparative study of clonidine and labetalol in severe hypertension induced by pregnancy 5th International Congress for the International Society for the study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, England 1986 136"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0020-7292(95)02372-J","article-title":"Oral nifedipine therapy in the management of severe preeclampsia","volume":"49","author":"Kwawukume","year":"1995","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.preghy.2012.04.198","article-title":"Deep trial secondary analysis: Digoxin immune fab fragment treatment has additional benefits in endogenous digitalis-like factor positive preeclamptic women","volume":"2","author":"Graves","year":"2012","journal-title":"Pregnancy Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD001449.pub3-BIB0091|cit91","first-page":"1053","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia: The pilot randomised controlled NOH-PE trial","volume":"106","author":"Gris","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.AOG.0000207637.01824.fe","article-title":"Effect of L-Arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial","volume":"107","author":"Hladunewich","year":"2006","journal-title":"Obstetrics & Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0093|cit93","first-page":"460","article-title":"In-vivo reversal of functional sodium pump inhibition with Digibind treatment","volume":"27","author":"Hopate","year":"2008","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0094|cit94","first-page":"812","article-title":"A controlled clinical trial of guanethidine in toxemia of pregnancy","volume":"17","author":"Daftary","year":"1963","journal-title":"Indian Journal of Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0095|cit95","first-page":"71","article-title":"Management of eclampsia with magnesium sulphate and nifedipine","volume":"51","author":"Samal","year":"2001","journal-title":"Journal of Obstetrics and Gynecology of India"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0096|cit96","first-page":"121","article-title":"The effect of nifedipin on the BP of the patients with severe preeclampsia","volume":"46","author":"Ghahiri","year":"1994","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0097|cit97","first-page":"331","article-title":"Nifedipine in the treatment of severe preeclampsia","volume":"77","author":"Fenakel","year":"1991","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0895-7061(98)00249-0","article-title":"The effect of isosorbide dinitate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension","volume":"12","author":"Thaler","year":"1999","journal-title":"American Journal of Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD001449.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1160\/TH03-06-0388","article-title":"Efficacy of AT in pre-eclampsia: a case control prospective trial","volume":"91","author":"Paternoster","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/01443619964977","article-title":"An open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsia","volume":"19","author":"Fletcher","year":"1999","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD001449.pub3-BIB0101|cit101","first-page":"27","article-title":"An open trial comparing usual care (hydralazine) with injectable isradipine in severe pre-eclampsia [abstract]","volume":"45","author":"Fletcher","year":"1996","journal-title":"West Indian Medical Journal"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.jhh.1000783","article-title":"A new treatment of severe pre-eclampsia by long term epidural anaesthesia","volume":"13","author":"Kanayama","year":"1999","journal-title":"Journal of Human Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/s-0037-1614071","article-title":"Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. Bi51.017 Study group","volume":"84","author":"Maki","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(01)00569-0","article-title":"Long-term treatment with nicardipine for severe pre-eclampsia","volume":"76","author":"Seki","year":"2002","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"6","key":"10.1002\/14651858.CD001449.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-2004-815632","article-title":"Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study","volume":"29","author":"Kobayashi","year":"2003","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0106|cit106","unstructured":"Johnston A Efficacy study of digibind for treatment of severe preeclampsia (ongoing trial) ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0107|cit107","first-page":"422","article-title":"Antepartum administration of a digoxin immune fab (Digibind) improves renal function in patients with severe preeclampsia","volume":"27","author":"Lam","year":"2008","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1447-0756.1996.tb00930.x","article-title":"Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice","volume":"22","author":"Jegasothy","year":"1996","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"5-6","key":"10.1002\/14651858.CD001449.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1440-1681.2007.04838.x","article-title":"Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial","volume":"35","author":"Manzur-Verastegui","year":"2008","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0110|cit110","unstructured":"Sandoval JB Perez FR Study of glomerular filtration in toxemia of pregnancy. Modifications with the use of furosemid (lasix) [abstract] 5th World Congress of Gynecology and Obstetrics; 1967; Sydney, Australia 1967 891"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000010278","article-title":"Sublingual isosorbide dinitrate in the acute control of hypertension in patients with severe preeclampsia","volume":"50","author":"Martinez-Abundis","year":"2000","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0112|cit112","first-page":"203","article-title":"New therapeutics alternative in severe preeclampsia","volume":"72","author":"Pardo-Morales","year":"2004","journal-title":"Cirugia y Cirujanos"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001449.pub3-BIB0113|cit113","first-page":"47","article-title":"Oral n-acetylcysteine supplementation does not prolong pregnancy in women with severe preeclampsia: a randomised, placebo-controlled trial [abstract]","volume":"21","author":"Roes","year":"2002","journal-title":"Hypertension in Pregnancy"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0114|cit114","unstructured":"Lubbe W Maternal and fetal responses to b-blockers with and without ISA in hypertensive pregnancy 5th International Congress for the International Society for the study of Hypertension in Pregnancy; 1986 July 7-10; Nottingham, England 1986 89"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1479-828X.1992.tb02846.x","article-title":"Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension","volume":"32","author":"Duggan","year":"1992","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0116|cit116","doi-asserted-by":"crossref","unstructured":"Decano MB Cabrera LT The effects of transdermal nitroglycerin (nitrol patch) on the uterine and umbilical artery blood flow in preeclampsia: a randomized double blind placebo controlled study [abstract] XVI FIGO World Congress of Obstetrics & Gynecology; 2000 Sept 3-8; Washington DC, USA (Book 1) 2000 26","DOI":"10.1016\/S0020-7292(00)82035-4"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0117|cit117","first-page":"658A","article-title":"Removal of agonistic autoantibodies against the angiotensin AT receptor in patients with preeclampsia [abstract]","volume":"17","author":"Pogue","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001449.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2005.09.007","article-title":"Oral n-acetylcysteine administration does not stabilise the process of established severe preeclampsia","volume":"127","author":"Roes","year":"2006","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10641950802601278","article-title":"A randomised, double-blinded, placebo-controlled trial of the phosphodiesterase type 5 inhibitor sildenafil in the treatment of preeclampsia","volume":"28","author":"Samangaya","year":"2009","journal-title":"Hypertension in Pregnancy"},{"issue":"2","key":"10.1002\/14651858.CD001449.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/10641955.2010.484083","article-title":"Phosphodiesterase inhibitor effect on small artery function in preeclampsia","volume":"30","author":"Samangaya","year":"2011","journal-title":"Hypertension in Pregnancy"},{"issue":"2","key":"10.1002\/14651858.CD001449.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.mehy.2004.02.018","article-title":"Hyperuricaemia and preeclampsia: is there a pathogenic link?","volume":"63","author":"Schackis","year":"2004","journal-title":"Medical Hypotheses"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0122|cit122","first-page":"168","article-title":"Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared","volume":"59","author":"Walker","year":"1983","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1479-828X.1971.tb00458.x","article-title":"A comparison of hypotensive drugs in patients with hypertensive disorders in late pregnancy","volume":"11","author":"Ratnam","year":"1971","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD001449.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.ajog.2005.10.282","article-title":"Oral labetalol given to treated non hypertensive patients with preeclampsia is no more likely to cause hypotension than magnesium sulfate [abstract]","volume":"193","author":"Smith","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0125|cit125","first-page":"371","article-title":"Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy","volume":"B1","author":"Garden","year":"1982","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0126|cit126","first-page":"279","article-title":"Low-dose diazoxide in the emergency management of severe hypertension in pregnancy","volume":"65","author":"Sankar","year":"1984","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/0002-9378(93)90383-T","article-title":"Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine","volume":"168","author":"Bhorat","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0128|cit128","unstructured":"Bhorat IE Naidoo DP Rout CC Moodley J Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine Proceedings of 9th International Congress, International Society for the Study of Hypertension in Pregnancy; 1994 march 15-18; Sydney, Australia 1994 162"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0301-2115(01)00611-X","article-title":"The optimal dosage of ketanserin for pateints with severe hypertension in pregnancy","volume":"102","author":"Schie","year":"2002","journal-title":"European Journal Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0130|cit130","unstructured":"Cararach V Torres Pons PJ Roca M Codina C Cobo E Gonzalez-Merlo J Treatment of severe hypertension in pregnancy. Double blind controlled trial a treatment pattern (TP) with hydralazine + methyldopa a single TP with labetolol Proceedings of 6th International Congress, International Society for the Study of Hypertension in Pregnancy; 1988 May 22-26; Montreal, Canada 1988 101"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0131|cit131","unstructured":"Steyn DW Hall DR Odendaal H The optimal dosage of nifedipine in patients with early onset severe pre-eclampsia - a randomised controlled trial 22nd Conference on Priorities in Perinatal Care in South Africa; 2003 March 11-14; Free State, South Africa 2003"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/00016349309021152","article-title":"Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants","volume":"72","author":"Hjertberg","year":"1993","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0134|cit133","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/jpme.1993.21.1.69","article-title":"Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment","volume":"21","author":"Hjertberg","year":"1993","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0133|cit134","unstructured":"Hjertberg R Faxelius G Lagercrantz H Neonatal adaptation in hypertensive pregnancy - a study of labetalol vs hydralazine treatment Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5-8; Helsinki, Finland 1994 18"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1749-6632.2009.03838.x","article-title":"Scientific rationale and design of a phase I safety study of relaxin in women with severe preeclampsia","volume":"1160","author":"Unemori","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD001449.pub3-BIB0136|cit136","first-page":"S18","article-title":"Randomized double blinded hemodynamic study of oral nifedipine and IV labetolol in hypertensive urgencies of pregnancy","volume":"180","author":"Scardo","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9378(99)70315-7","article-title":"A randomized double blind hemodynamic evaluation of nifedipine and labetolol in preeclamptic hypertensive emergencies","volume":"181","author":"Scardo","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD001449.pub3-BIB0138|cit138","first-page":"S14","article-title":"A prospective randomized double blind trial of oral nifedipine and intravenous labetolol in hypertensive emergencies","volume":"180","author":"Vermillion","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0002-9378(99)70314-5","article-title":"A randomized double blind trial of oral nifedipine and intravenous labetolol in hypertensive emergencies of pregnancy","volume":"181","author":"Vermillion","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Pt 2","key":"10.1002\/14651858.CD001449.pub3-BIB0140|cit140","first-page":"486","article-title":"Effect of transdermal nitroglycerin on umbilical artery blood flow in preeclampsia [abstract]","volume":"29 Suppl 1","author":"Reyna-Villasmil","year":"2001","journal-title":"Journal of Perinatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0141|cit141","first-page":"521","article-title":"Comparison of intravenous hydralazine-bolus dose versus continuous infusion drip in eclampsia","volume":"11","author":"Waheed","year":"2005","journal-title":"Annals of King Edward Medical College"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0142|cit142","unstructured":"Chandran JR Devi U Devi S Khadeeja M Vinayachandran S Jacob KJ LAMPET Trial (labetalol vs magnesium sulfate in prevention of eclampsia trial) 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India 2011 55"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001449.pub3-BIB0143|cit143","first-page":"9","article-title":"First interim report on the labetalol versus magnesium sulfate for the prevention of eclampsia trial (LAMPET) [abstract]","volume":"23","author":"Warren","year":"2004","journal-title":"Hypertension in Pregnancy"},{"issue":"2","key":"10.1002\/14651858.CD001449.pub3-BIB0144|cit144","first-page":"103","article-title":"The use of hydralazine and nifedipine in hypertensive emergencies in pregnancy","volume":"17","author":"Mesquita","year":"1995","journal-title":"Revista Brasileira de Ginecologia e Obstetricia"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0145|cit145","unstructured":"Diemunsch PA Treatment of severe hypertension during pre-eclampsia. A preliminary equivalence study between urapidil and nicardipine ClinicalTrials.gov (http:\/\/clinicaltrials.gov\/)"},{"issue":"1","key":"10.1002\/14651858.CD001449.pub3-BIB0146|cit146","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002252.pub2","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","author":"Abalos","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD001449.pub3-BIB0147|cit147","first-page":"1","article-title":"Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom","volume":"118","author":"Cantwell","year":"2011","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0148|cit148","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003106","article-title":"Interventionist versus expectant care for severe pre-eclampsia before term","author":"Churchill","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0149|cit149","unstructured":"Clarke M Oxman AD Cochrane Reviewers\u2019 Handbook 4.1.5 [updated April 2002] In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software. Updated quarterly"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/9780470752371.ch6","article-title":"Hypertension","volume-title":"Medical Disorders in Obstetric Practice","author":"Redman","year":"2002"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001805","article-title":"Plasma volume expansion for treatment of pre-eclampsia","author":"Duley","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001449.pub3-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007756","article-title":"Interventions for treating pre-eclampsia and its consequences: generic protocol","author":"Duley","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD001449.pub3-BIB0153|cit153","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000025.pub2","article-title":"Magnesium sulphate and other anticonvulsants for women with pre-eclampsia","author":"Duley","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD001449.pub3-BIB0154|cit154","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002960.pub2","article-title":"Magnesium sulphate versus lytic cocktail for eclampsia","author":"Duley","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001449.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1479-828X.2007.00738.x","article-title":"A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial","volume":"47","author":"Hennessy","year":"2007","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0156|cit156","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD001449.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jash.2008.10.001","article-title":"Hypertension in pregnancy","volume":"2","author":"Lindheimer","year":"2008","journal-title":"Journal of the American Society of Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1479-828X.2009.01003.x","article-title":"Guidelines for the management of hypertensive disorders of pregnancy","volume":"49","author":"Lowe","year":"2009","journal-title":"Australia and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"issue":"Supp 1","key":"10.1002\/14651858.CD001449.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32776-1","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"30","author":"Magee","year":"2008","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0161|cit161","unstructured":"National Institute of Clinical Excellence NICE clinical guideline No. 107. Hypertension in Prenancy. Management of Hypertensive Disorders in Pregnancy http:\/\/www.nice.org.uk\/nicemedia\/live\/13098\/50418\/50418.pdf 2010"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0162|cit162","unstructured":"The Cochrane Collaboration Review Manager (RevMan) 2000"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0163|cit163","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001449.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"issue":"8","key":"10.1002\/14651858.CD001449.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/10641960802580232","article-title":"Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies","volume":"30","author":"Tomassoni","year":"2008","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0166|cit166","volume-title":"The management of severe pre-eclampsia\/eclampsia. RCOG guideline number 10(A)","author":"Tuffnell","year":"2006"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9378(88)90782-X","article-title":"Geographic variation in the incidence of hypertension in pregnancy","volume":"158","author":"World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy","year":"1988","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0168|cit168","unstructured":"World Health Organization WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241548335_eng.pdf (accessed 2013) 2011"},{"issue":"9","key":"10.1002\/14651858.CD001449.pub3-BIB0169|cit169","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008148.pub2","article-title":"Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy","author":"Woudstra","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0170|cit170","unstructured":"Duley L IV labetalol vs iv diazoxide in severe pre-eclampsia In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0171|cit171","unstructured":"Duley L Labetalol vs hydralazine in severe pregnancy-induced hypertension In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0172|cit172","unstructured":"Duley L Nifedipine vs hydralazine in severe pregnancy-induced hypertension In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995"},{"key":"10.1002\/14651858.CD001449.pub3-BIB0173|cit173","unstructured":"Duley L Prostacyclin vs dihydralazine in severe hypertension In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database Issue 2, Oxford: Update Software 1995"},{"issue":"2","key":"10.1002\/14651858.CD001449.pub3-BIB0174|cit174","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001449","article-title":"Drugs for rapid treatment of very high blood pressure during pregnancy","author":"Duley","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0175|cit175","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001449","article-title":"Drugs for rapid treatment of very high blood pressure during pregnancy","author":"Duley","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD001449.pub3-BIB0176|cit176","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001449.pub2","article-title":"Drugs for treatment of very high blood pressure during pregnancy","author":"Duley","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001449.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T20:12:52Z","timestamp":1730059972000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001449.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pregnancy and Childbirth Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,31]]},"references-count":176,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001449.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,31]]}}}